Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Clinical Trial Launches to Test Bundibugyo Virus Treatments
July 2026
Patient enrolment has begun in the PARTNERS clinical trial evaluating potential antiviral treatments for Bundibugyo virus disease in the DRC.
Read more
5 Mar 2024
Can High-Dose Vitamin D Supplements Reduce Repeat Pneumonia Episodes in Children?
A systematic review regarding the benefits of using high-dose vitamin D supplements in paediatric populations was presented at the 8th Respiratory Syncytial Virus Foundation (ReSViNET) Conference. Researchers found that the use of vitamin D does not reduce rates of mortality in paediatric patients with pneumonia.
4 Mar 2024
Identifying Preterm Infants at Risk of Respiratory Syncytial Virus Hospitalisation
Research presented at the 8th Respiratory Syncytial Virus Network (ResViNET) Conference identified a risk scoring tool (RST) for classifying moderate-to-late preterm infants at greatest risk of respiratory syncytial virus (RSV) hospitalisation.
28 Feb 2024
Artificial Intelligence Could Identify Risk of Sexually Transmitted Infections
A new artificial intelligence tool, called ‘MySTIRisk’, has successfully determined infection risk scores for HIV, syphilis, gonorrhoea, and chlamydia. Read more.
11 Jan 2024
Risks of Invasive Fungal Infections Following Lung Transplant
Risk factors of invasive fungal infections for lung transplant recipients receiving universal antifungal treatment varied in terms of early and late infections, as well as invasive-mould type infections.
11 Jan 2024
Prenatal Influenza Vaccination Reduces Illness in Infants
Maternal influenza vaccination during pregnancy is linked with a reduction in the number of influenza-associated visits to the emergency department in infants aged younger than 6 months. Read more.
4 Dec 2023
Impact of In-House PCR Testing for
Candida auris
on Hospital-Onset Cases
Testing for Candida auris on patient admission helped to identify more cases, and reduced the number of hospital-onset cases, according to a new study. Read more.
4 Dec 2023
Patients with HIV at Risk for Mental Health Disorders
According to research, people with an HIV diagnosis are more likely to develop a mental health disorder, such as anxiety and depression. Patients who are not receiving treatment for HIV were at an even higher risk.
30 Oct 2023
Use of Antifungal Therapeutic Drug Monitoring Needs Improvement
A recent study has found that adherence to antifungal therapeutic drug monitoring is moderate-to-high in patients, although there is room for improvement, largely as a result of long turnaround times and uncertainty surrounding the monitoring process.
Loading posts...
« Previous
1
…
40
41
42
43
44
…
50
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View